GIM
JNJ icon

Glenmede Investment Management’s Johnson & Johnson JNJ Stock Holding History

Glenmede Investment Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$265M Sell
1,428,293
-17,145
-1% -$2.94M 1.28% 10
2025
Q2 		$221M Buy
+1,445,438
New +$222M 1.12% 13

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Glenmede Investment Management's JNJ Position: Q3 2025 in Review

Glenmede Investment Management reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q3 2025, selling an estimated $2.94M and leaving 1,428,293 shares worth $265M. The position accounts for 1.28% of the portfolio, ranked #10.

Glenmede Investment Management first reported a position in JNJ in Q2 2025 and has held it in 2 quarters since. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Glenmede Investment Management held 1,428,293 shares of Johnson & Johnson worth $265M as of Q3 2025.
  • Glenmede Investment Management sold 17,145 Johnson & Johnson shares in Q3 2025, an estimated $2.94M.
  • Johnson & Johnson made up 1.28% of Glenmede Investment Management's portfolio in Q3 2025, its #10 holding.
  • Glenmede Investment Management first reported a position in Johnson & Johnson in Q2 2025 and has held it in 2 quarters since.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.